Immuneering Corporation Class A Common Stock — Quarterly Financial Statements (NASDAQ:IMRX) | MetaTrader

Open full chart

Financials

Overview Отчетность Statistics Dividends

Quarterly Annual

Market Capitalization 197.95 M
Employee 54
Founded 2008
CEO N/A
Website www.immuneering.com
Headquarter Delaware, United States
FIGI BBG009QXJQS1
Industry Technology

Total revenue

Net income

Basic earnings per share (Basic EPS)

Total debt

Free cash flow

Cash & equivalents

197.95 M Market capitalization

Price to earnings ratio

-3.91

Price to sales ratio

—

Dividends per share

—

Dividend yield %

—

Новости

Immuneering’s (IMRX) chief business officer buys $24,990 in stock

Директор Immuneering Шалл приобрел акции на сумму $101 тыс.

Директор Immuneering Файнберг приобрел акции на $86 тыс.

Immuneering: Strong Buy Despite Decline In Share Price On Atebimetinib Data (NASDAQ:IMRX)

U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.55%

Рынок акций США закрылся разнонаправленно, Dow Jones прибавил 0,55%

Alibaba, Costco among market cap stock movers on Thursday

Costco, Alibaba among market cap stock movers on Thursday

Dow Jumps Over 250 Points; US Initial Jobless Claims Increase - Acrivon Therapeutics (NASDAQ:ACRV), Cormedix (NASDAQ:CRMD)

Nasdaq Falls Over 100 Points; Acuity Posts Upbeat Earnings - Acrivon Therapeutics (NASDAQ:ACRV), Acuity (NYSE:AYI)

Why Is Immuneering Stock Trading Lower Today? - Immuneering (NASDAQ:IMRX)

Immuneering, Phathom Pharmaceuticals, Canadian Solar And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Canadian Solar (NASDAQ:CSIQ), Elme (NYSE:ELME)